Skip to main content
Clinical Trials/JPRN-UMIN000033333
JPRN-UMIN000033333
Completed
未知

The prospective study of the preventive effect of supraorbital transcutaneous stimulation using the Cefaly(R) device against frequent episodic migraine and chronic migraine - The prospective study of the preventive effect of supraorbital transcutaneous stimulation using the Cefaly(R) device against frequent episodic migraine and chronic migraine

Tominaga Hospital0 sites100 target enrollmentJuly 10, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Migraine with and without aura, including chronic migraine (ICHD-3beta 1.1, 1.2.1, or 1.3)
Sponsor
Tominaga Hospital
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 10, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)The subjects who changed their prophylaxis within the previous 3 months 2\)The subjects who received BOTOX or a nerve block within the previous 3 months 3\)The subjects with any secondary headache except for MOH 4\)The subjects who have severe neurologic and/or psychiatric disorders 5\)The subjects who have epilepsy 6\)Pregnant or breast\-feeding women 7\)The subjects who have severe heart, liver, and/or renal dysfunction 8\)The subjects who are using opioids 9\)The subjects who have allodynia 10\)The subjects who have metal and/or electrical device in their body 11\)The subjects who are using cardiac pace\-maker and/or implantable cardioverter\-defibrillator 12\)The subjects whom investigators estimate are not eligible

Outcomes

Primary Outcomes

Not specified

Similar Trials